BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 14599290)

  • 1. AlphaII-spectrin is an in vitro target for caspase-2, and its cleavage is regulated by calmodulin binding.
    Rotter B; Kroviarski Y; Nicolas G; Dhermy D; Lecomte MC
    Biochem J; 2004 Feb; 378(Pt 1):161-8. PubMed ID: 14599290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways.
    Zhang Z; Larner SF; Liu MC; Zheng W; Hayes RL; Wang KK
    Apoptosis; 2009 Nov; 14(11):1289-98. PubMed ID: 19771521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential degradation of alphaII and betaII spectrin by calpain in glutamate or maitotoxin-stimulated cells.
    Glantz SB; Cianci CD; Iyer R; Pradhan D; Wang KK; Morrow JS
    Biochemistry; 2007 Jan; 46(2):502-13. PubMed ID: 17209560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the calmodulin alphaII-spectrin complex provides insight into the regulation of cell plasticity.
    Simonovic M; Zhang Z; Cianci CD; Steitz TA; Morrow JS
    J Biol Chem; 2006 Nov; 281(45):34333-40. PubMed ID: 16945920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlphaII-spectrin interacts with Tes and EVL, two actin-binding proteins located at cell contacts.
    Rotter B; Bournier O; Nicolas G; Dhermy D; Lecomte MC
    Biochem J; 2005 Jun; 388(Pt 2):631-8. PubMed ID: 15656790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility.
    Stabach PR; Cianci CD; Glantz SB; Zhang Z; Morrow JS
    Biochemistry; 1997 Jan; 36(1):57-65. PubMed ID: 8993318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calmodulin stimulates the degradation of brain spectrin by calpain.
    Seubert P; Baudry M; Dudek S; Lynch G
    Synapse; 1987; 1(1):20-4. PubMed ID: 2850618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutant alphaII-spectrin designed to resist calpain and caspase cleavage questions the functional importance of this process in vivo.
    Meary F; Metral S; Ferreira C; Eladari D; Colin Y; Lecomte MC; Nicolas G
    J Biol Chem; 2007 May; 282(19):14226-37. PubMed ID: 17374614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of spectrin-actin assembly by erythrocyte adducin.
    Gardner K; Bennett V
    Nature; 1987 Jul 23-29; 328(6128):359-62. PubMed ID: 3600811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis.
    Berg CP; Engels IH; Rothbart A; Lauber K; Renz A; Schlosser SF; Schulze-Osthoff K; Wesselborg S
    Cell Death Differ; 2001 Dec; 8(12):1197-206. PubMed ID: 11753567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats.
    Pike BR; Flint J; Dave JR; Lu XC; Wang KK; Tortella FC; Hayes RL
    J Cereb Blood Flow Metab; 2004 Jan; 24(1):98-106. PubMed ID: 14688621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Src binds alpha II spectrin's Src homology 3 (SH3) domain and blocks calpain susceptibility by phosphorylating Tyr1176.
    Nedrelow JH; Cianci CD; Morrow JS
    J Biol Chem; 2003 Feb; 278(9):7735-41. PubMed ID: 12446661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA.
    Warren MW; Larner SF; Kobeissy FH; Brezing CA; Jeung JA; Hayes RL; Gold MS; Wang KK
    Acta Neuropathol; 2007 Sep; 114(3):277-86. PubMed ID: 17647000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of alphaII spectrin to 14-3-3beta is involved in NCAM-dependent neurite outgrowth.
    Ramser EM; Buck F; Schachner M; Tilling T
    Mol Cell Neurosci; 2010 Sep; 45(1):66-74. PubMed ID: 20598904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliotoxin induces caspase-dependent neurite degeneration and calpain-mediated general cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells.
    Axelsson V; Holback S; Sjögren M; Gustafsson H; Forsby A
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1068-74. PubMed ID: 16712786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of calpain and caspase systems activities during ageing of two bovine muscles by degradation patterns of αII spectrin and PARP-1.
    Saccà E; Pizzutti N; Corazzin M; Lippe G; Piasentier E
    Anim Sci J; 2016 Mar; 87(3):462-6. PubMed ID: 26950517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition.
    DeRidder MN; Simon MJ; Siman R; Auberson YP; Raghupathi R; Meaney DF
    Neurobiol Dis; 2006 Apr; 22(1):165-76. PubMed ID: 16356733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous degradation of alphaII- and betaII-spectrin by caspase 3 (CPP32) in apoptotic cells.
    Wang KK; Posmantur R; Nath R; McGinnis K; Whitton M; Talanian RV; Glantz SB; Morrow JS
    J Biol Chem; 1998 Aug; 273(35):22490-7. PubMed ID: 9712874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alpha II spectrin mutant peptide with unstable scaffold structure and increased sensitivity to calpain cleavage.
    Skrzymowska J; Zalas M; Goszczyński TM; Miazek A
    Biochem Biophys Res Commun; 2021 Dec; 581():68-73. PubMed ID: 34656850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent ataxia and neurodegeneration caused by an αII spectrin mutation with impaired regulation of its calpain sensitivity.
    Miazek A; Zalas M; Skrzymowska J; Bogin BA; Grzymajło K; Goszczynski TM; Levine ZA; Morrow JS; Stankewich MC
    Sci Rep; 2021 Mar; 11(1):7312. PubMed ID: 33790315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.